Q1 2021 13F Holders as of 31 Mar 2021
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
54,486,781
-
Total 13F shares
-
44,459,246
-
Share change
-
+669,386
-
Total reported value
-
$4,122,801,151
-
Put/Call ratio
-
117%
-
Price per share
-
$92.91
-
Number of holders
-
334
-
Value change
-
+$64,719,540
-
Number of buys
-
158
-
Number of sells
-
182
Institutional Holders of Emergent BioSolutions Inc. - Common Stock (EBS) as of Q1 2021
As of 31 Mar 2021 Emergent BioSolutions Inc. - Common Stock (EBS) had 334 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 44,459,246 shares of stock of the company.
Largest 10 holders included BlackRock Inc., VANGUARD GROUP INC, Neuberger Berman Group LLC, JANUS HENDERSON GROUP PLC, STATE STREET CORP, EARNEST PARTNERS LLC, MANUFACTURERS LIFE INSURANCE COMPANY, THE, DIMENSIONAL FUND ADVISORS LP, Invesco Ltd., and GEODE CAPITAL MANAGEMENT, LLC.
This table shows 334 institutional shareholders of the security as of 31 Mar 2021.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.